RN7SL239P

Across TCGA pan-cancer cohorts, RN7SL239P RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of RN7SL239P’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RN7SL239P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL239P is over-expressed in tumor.

HNSC, STAD, and BRCA are the cancer types where RN7SL239P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL239P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.169	<.001	9	view →
STAD	All	II,III,IV	+0.473	<.001	6	view →
BRCA	All	All	+0.301	<.001	6	view →
CHOL	Male	All	+0.716	<.001	4	view →
LUAD	All	All	+0.412	.001	4	view →
BLCA	All	III,IV	+0.325	.013	4	view →
COAD	Male	II,III,IV	+0.270	.013	4	view →
LIHC	All	All	+0.076	.006	4	view →
LUSC	Male	All	+0.190	.025	3	view →
READ	All	All	+0.325	.022	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

RN7SL239P–HNSC

Open the HNSC breakdown →